Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

First-in-line subcutaneous injectable for reversible, non-hormonal male contraception

Drug Delivery and Translational Research(2025)10.1007/s13346-025-01871-3Source: DataRank Database

First-in-line subcutaneous injectable for reversible, non-hormonal male contraception is a research paper published in Drug Delivery and Translational Research (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 0.00)OA: closedTopics (53)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

James K. Tsuruta ORCID,Andres Prieto Trujillo,Roopali Shrivastava ORCID,Ava Cohen,Rani S. Sellers ORCID

Live enrichment

PubMed:40425996 OpenAlex:https://openalex.org/W4410840526

Male Contraception Initiative

Grant: David Sokal Award

National Science Foundation Graduate Research Fellowship Program

Grant: DGE-2040435

North Carolina Biotech Center Institutional Support Grant

Grant: 2017-IDG-1025

National Institutes of Health

Grant: 1UM2AI30836-01

NIH-NICHD

Grant: P50 HD103573

National Institutes of Health

Grant: 5P50HD103573-03

Clinical Translational Research Center for Neurodevelopmental Disorders

National Science Foundation

Grant: 2040435

Graduate Research Fellowship Program (GRFP)

FWCI

0.00

Citation Percentile

0.1%

closedLicense: Springer Nature TDM

publisherhttps://link.springer.com/content/pdf/10.1007/s13346-025-01871-3.pdf

publisherhttps://link.springer.com/article/10.1007/s13346-025-01871-3/fulltext.html

journalhttps://doi.org/10.1007/s13346-025-01871-3

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40425996

Fields of Study

Reproductive Health and ContraceptionHormonal and reproductive studiesSexual Differentiation and Disorders03 medical and health sciences0302 clinical medicineMaleAnimalsContraceptive Agents, MaleMice, Inbred BALB CInjections, SubcutaneousDrug ImplantsDelayed-Action PreparationsSperm MotilityMiceDrug LiberationContraception

MeSH Terms

AnimalsContraceptionContraceptive Agents, MaleDelayed-Action PreparationsDrug ImplantsInjections, SubcutaneousMaleMice, Inbred BALB CSperm MotilityMiceDrug Liberation

Keywords

Hormonal contraceptionHormoneMedicineSubcutaneous injectionLine (geometry)GynecologyPhysiologyFamily planningInternal medicinePopulationResearch methodologyMale ContraceptionIn-situ Forming ImplantNon-hormonal ContraceptionEppin-inhibitorMaleDrug ImplantsMice, Inbred BALB CMiceDrug LiberationContraceptionInjections, SubcutaneousDelayed-Action PreparationsContraceptive Agents, MaleSperm MotilityAnimals

Sustainable Development Goals

SDG 0: Good health and well-being

First-in-line subcutaneous injectable for reversible, non-hormonal male contraception

FAIR Checklist

Authors (9)

Funding (7 grants)

Impact

Open Access

Topics